Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Top fashion brands have a supply chain battle against extreme India heat
As Indian garment factories contend with soaring temperatures, worker efficiency and health have been jeopardised. Epic Group's facility in Odisha has introduced cutting-edge cooling technology to combat these challenges. Employees have reported substantial improvements in concentration and comfort in the climate-managed setting.
Government notifies Navi Mumbai Airport as a Port for Import of drugs under Drug Rules
The Ministry of Health has enabled drug imports through Navi Mumbai Airport. This amendment strengthens the pharmaceutical supply chain and trade facilitation. Navi Mumbai Airport now joins other designated ports for drug importation. The total number of entry points for drugs has increased to forty-two. This initiative promotes ease of doing business and regulatory oversight.
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash
Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic demand and positive global healthcare trends. Analysts see long-term growth potential from aging populations and innovation. Emerging opportunities from supply chain diversification away from China also present a positive outlook for Indian pharmaceutical companies.
Cipla wants new-age medicines to contribute 10% of revenue in five years
Cipla is expanding its innovation ambitions while building manufacturing capacity in the US, as the drugmaker looks to diversify revenue streams and strengthen supply-chain resilience amid increasing regulatory and localisation pressures in global pharmaceutical markets.
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces patients to search extensively for medication. Some drugmakers have reduced production. The situation puts immense pressure on the healthcare system and patients seeking treatment.
P&G Health stock surges 18% after solid Q4 results; PAT jumps 56% YoY
P&G Health reported a net profit of ₹95 crore, up 56 per cent Y-o-Y, driven by superior brand-building activities and supported by strengthened supply chain and go-to-market capabilities
Nifty could hit 27,000 once geopolitical tensions ease: Bajaj Finserv AMC CIO
Bajaj Finserv AMC CIO Nimesh Chandan projects 15% earnings growth for Nifty in FY28, with EPS rising to the ₹1,420–1,440 range, making valuations look attractive. He backs metals, construction, and cement as long-term plays on a global supply chain shift, holds gold and silver in the multi-asset portfolio, and flags El Niño and elevated US yields as key risks keeping Indian interest rates high in the near term.
US market outlook stable; India to gain from supply chain shift: Oppenheimer Asset Management
John Stoltzfus, MD and Chief Investment Strategist, Oppenheimer Asset Management, said that over the medium term, diversification of global supply chains and sectoral strengths in technology, healthcare, and manufacturing are expected to support growth across regions, including a potential recovery in India’s relative performance.
CureBay absorbs Saveo's pharma distribution unit to expand rural reach
CureBay has acquired Saveo’s pharma distribution business to strengthen its rural supply chain and accelerate its full-stack healthcare model across underserved regions.
Reliance Industries analysts do not see more downside on the stock; Check latest targets
Even if tensions ease soon, supply chain normalisation could take longer, keeping product cracks elevated and supporting refining and petrochemical margins.